Nucleix

Nucleix develops non-invasive liquid-biopsy technology for early cancer detection by identifying tumor DNA and methylation patterns in fluid samples.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2021